Arrigo, Alessandro http://orcid.org/0000-0003-4715-8414
Saladino, Andrea
Aragona, Emanuela
Barresi, Costanza
Mularoni, Cecilia
Bandello, Francesco
Battaglia Parodi, Maurizio
Article History
Received: 30 November 2023
Accepted: 31 January 2024
First Online: 6 March 2024
Declarations
:
: Francesco Bandello consultant for: Alcon (Fort Worth, TX, USA), Alimera Sciences (Alpharetta, GA, USA), Allergan Inc (Irvine, CA, USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering-Pharma (Berlin, Germany), Bausch & Lomb (Rochester, NY, USA), Genentech (San Francisco, CA, USA), Hoffmann-La-Roche (Basel, Switzerland), NovagaliPharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee, Belgium), Zeiss (Dublin, CA, USA). Alessandro Arrigo, Andrea Saladino, Emanuela Aragona, Costanza Barresi, Cecilia Mularoni and Maurizio Battaglia Parodi have nothing to disclose.
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the ethical committee of IRCCS Scientific Institute San Raffaele Hospital (MIRD). The study used non-identifiable data and all the patients provided informed consent.